Hikma Pharmaceuticals Plc Publication of Offering Circular (2852S)
July 07 2020 - 7:48AM
UK Regulatory
TIDMHIK
RNS Number : 2852S
Hikma Pharmaceuticals Plc
07 July 2020
Hikma Finance USA LLC
Publication of Offering Circular
7 July 2020
Hikma Finance USA LLC (the "Issuer") announces today that it has
published an offering circular dated 7 July 2020 (the "Offering
Circular") in connection with the issuance of US$500,000,000 3.250
per cent. Guaranteed Notes due 2025 (the "Notes") guaranteed by
Hikma Pharmaceuticals PLC, Al Jazeerah Pharmaceutical Industries
Ltd, Arab Pharmaceutical Manufacturing PSC, Eurohealth (U.S.A.),
Inc., Hikma Farmacêutica (Portugal) S.A., Hikma Injectables USA
Inc., Hikma Labs Inc., Hikma Pharma S.A.E., Hikma Pharmaceuticals
International Limited, Hikma Pharmaceuticals LLC, Hikma
Pharmaceuticals USA Inc., Hikma Specialty USA Inc. and West-Ward
Columbus Inc.
The Notes are expected to be admitted to trading on the
International Securities Market of the London Stock Exchange on or
about 10 July 2020.
The Offering Circular is available for viewing.
To view the Offering Circular please paste the following URL
into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/2852S_1-2020-7-7.pdf
Enquiries and Investor Relations
Susan Ringdal
EVP, Strategic Planning and Global Affairs
+44 (0) 20 7399 2760 / +44 7776 477050
LEI: 213800BU7YH2WTM1QL87
Regulated Information Classification: Additional regulated
information required to be disclosed under the laws of a Member
State
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Offering
Circular may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Offering
Circular) only and is not intended for use and should not be relied
upon by any person outside these countries and/or to whom the offer
contained in the Offering Circular is not addressed. Prior to
relying on the information contained in the Offering Circular, you
must ascertain from the Offering Circular whether or not you are
one of the intended addressees of the information contained
therein.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
CIRKKOBQDBKDAOK
(END) Dow Jones Newswires
July 07, 2020 07:48 ET (11:48 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024